Le Li
Wuhan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Targeting oxidative phosphorylation to increase the efficacy of immune-combination therapy in renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: January 22, 2024
Targeting Alpha-Ketoglutarate Disruption Overcomes Immunoevasion and Improves PD-1 Blockade Immunotherapy in Renal Cell Carcinoma.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 27, 2023
Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics.
Journal: Journal of translational medicine
Published: January 08, 2023
Non-SMC condensin I complex subunit H participates in anti-programmed cell death-1 resistance of clear cell renal cell carcinomas.
Journal: Cell proliferation
Published: September 18, 2022
Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11.
Journal: Free radical biology & medicine
Published: January 20, 2022
Integrated Multi-Omics Analysis Identified PTPRG and CHL1 as Key Regulators of Immunophenotypes in Clear Cell Renal Cell Carcinoma(ccRCC).
Journal: Frontiers in oncology
Published: December 09, 2021
Three-dimensional (3D) reconstruction and navigation in robotic-assisted partial nephrectomy (RAPN) for renal masses in the solitary kidney: A comparative study.
Journal: The international journal of medical robotics + computer assisted surgery : MRCAS
Published: June 11, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026